Strain AI vs CardIQ Suite

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Strain AI

by Exo

CardIQ Suite

by GE Medical Systems SCS

AI Verdict

Strain AI analyzes cardiac ultrasound images to measure Global Longitudinal Strain, focusing on heart function and conditions like heart failure. CardIQ Suite, conversely, processes cardiac CT scans for automated calcium scoring and CCTA review, primarily aiding in the diagnosis of coronary artery disease. While both are AI-powered tools for cardiac imaging, they utilize different modalities and address distinct diagnostic needs within cardiology.

Choose Strain AI if…

Choose Strain AI if you require real-time, on-device AI analysis of cardiac ultrasound images to quickly assess global longitudinal strain (GLS) and evaluate heart function at the point of care. This tool is ideal for clinicians needing immediate insights into conditions like heart failure or cardiotoxicity without relying on an internet connection.

View Strain AI →

Choose CardIQ Suite if…

Choose CardIQ Suite if your workflow involves comprehensive post-processing of cardiac CT scans for detailed cardiovascular disease diagnosis and treatment planning. This solution excels in automated calcium scoring, CCTA review, and plaque burden quantification, providing in-depth anatomical and pathological insights from CT data.

View CardIQ Suite →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Strain AI	CardIQ Suite
Pricing	Contact for pricing	Contact for pricing
Deployment	On-device AI, operates without internet connection.	On-premise (GE Advantage Workstation (AW) and AW Server (AWS))
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Strain AI

Strain AI (Tool A) offers real-time, on-device AI insights that operate without an internet connection and integrate with existing ultrasound devices, simplifying the process of obtaining and interpreting medical images at the point of care. CardIQ Suite (Tool B), while providing an integrated and automated workflow for CT post-processing, is deployed on-premise within a specific GE workstation environment, which may limit its flexibility for broader point-of-care use.

Clinical Value

Tie

Both tools offer significant and validated clinical value in distinct areas of cardiac assessment. Strain AI (Tool A) excels in providing quantitative functional assessment by measuring Global Longitudinal Strain (GLS) to aid in detecting heart failure and cardiotoxicity. CardIQ Suite (Tool B) provides comprehensive anatomical assessment through automated calcium scoring and CCTA review for cardiovascular disease diagnosis and treatment planning, including plaque burden quantification.

Pricing & Value

Tie

Both Strain AI (Tool A) and CardIQ Suite (Tool B) require prospective customers to contact their respective companies for pricing information. Without transparent pricing details or specific return-on-investment studies, it is impossible to conduct a head-to-head comparison of their pricing and overall value.

Enterprise Readiness

Strain AI

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and Business Associate Agreements (BAAs). However, Strain AI's (Tool A) on-device, internet-independent deployment and integration with existing ultrasound devices offer greater flexibility and scalability for diverse clinical settings, potentially simplifying IT infrastructure requirements. CardIQ Suite (Tool B) is a robust solution but is tied to an on-premise GE Advantage Workstation environment, which might be less adaptable for certain enterprise deployments.

Innovation

Strain AI

While both leverage AI for advanced cardiac analysis, Strain AI (Tool A) demonstrates a more disruptive innovation by delivering real-time, on-device AI insights for complex functional measurements like Global Longitudinal Strain (GLS) on handheld ultrasound devices. This approach significantly advances point-of-care diagnostics. CardIQ Suite (Tool B) innovates with deep learning for automated, comprehensive CT cardiac post-processing, which is advanced but represents a more established application of AI in radiology workflows.

Support & Docs

Tie

Both Exo (for Strain AI) and GE HealthCare (for CardIQ Suite) appear to offer substantial support and documentation resources. Exo provides a 'Resources' section with various educational materials and support for POCUS workflow deployment. GE HealthCare offers a comprehensive 'Documentation Library' including product manuals and technical specifications. Without specific comparative data on the quality, responsiveness, or user satisfaction of their support services, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Strain AI	CardIQ Suite
Name	Strain AI	CardIQ Suite
Company	Exo	GE Medical Systems SCS
Primary Imaging Modality Analyzed	Cardiac ultrasound images	Cardiac CT
Core AI Functionality	Measures Global Longitudinal Strain (GLS), aids in assessing heart function and detecting conditions like heart failure and cardiotoxicity.	Automated calcium scoring and CCTA review for cardiovascular disease diagnosis and treatment planning.
Specialties Supported	Cardiology, Oncology, Radiology	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Strain AI and CardIQ Suite.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing cardiac imaging workflows and data management systems?

Strain AI integrates with existing ultrasound devices, providing real-time, on-device AI insights directly within the ultrasound workflow. CardIQ Suite offers an integrated workflow for seamless review of calcium scoring and CCTA data, designed for automation and efficiency within a CT post-processing environment.

For what specific clinical scenarios or patient populations is each tool best suited, given their different imaging modalities and analytical focuses?

Strain AI is best suited for assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients using cardiac ultrasound images to measure Global Longitudinal Strain (GLS). CardIQ Suite is designed for comprehensive cardiovascular disease diagnosis and treatment planning through automated calcium scoring and CCTA review using cardiac CT data.

What specific metrics or types of analysis do these tools provide, and how do they contribute to diagnostic evaluation?

Strain AI provides quantitative Global Longitudinal Strain (GLS) measurements from cardiac ultrasound images, aiding in assessing heart function without manual image interpretation. CardIQ Suite offers deep learning-based automated calcium scoring, CCTA 2D review with cine capability, and tools for visualizing and quantifying plaque burden, enhancing detailed cardiovascular assessment.

How quickly can a physician and their team become proficient in using each tool, and what is the expected time to realize clinical workflow benefits?

Strain AI delivers real-time, on-device AI insights and supports diagnostic evaluation without manual image interpretation, suggesting a potentially rapid integration into existing ultrasound workflows. CardIQ Suite is built for automation and workflow efficiency in CT cardiac post-processing, implying a streamlined process once integrated into the GE Advantage Workstation environment.

What are the key considerations for deploying each tool across multiple clinical sites, particularly regarding infrastructure?

Strain AI operates with on-device AI and without an internet connection, which simplifies multi-site deployment by reducing network infrastructure dependencies. CardIQ Suite requires on-premise deployment on GE Advantage Workstation (AW) and AW Server (AWS), meaning multi-site rollouts would involve deploying and managing these specific hardware and software environments at each location.

How do these tools ensure the traceability and integrity of the AI-generated analyses within the clinical record?

Strain AI provides quantitative strain measurements and real-time insights that integrate with existing ultrasound devices, which would typically be incorporated into the patient's record via established workflows. CardIQ Suite offers an integrated workflow for reviewing and managing calcium scoring and CCTA data, with its analyses forming part of a structured post-processing output that can be incorporated into the patient's diagnostic report.